Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-24T20:56:17.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.6%
    Check dated 2025-02-10T09:50:26.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T07:52:47.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    New information has been added regarding the safety and efficacy of Lebrikizumab in combination with topical corticosteroids for treating moderate-to-severe atopic dermatitis, provided by Eli Lilly and Company.
    Difference
    0.4%
    Check dated 2025-01-27T03:28:02.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T22:32:08.000Z thumbnail image
  9. Check
    63 days ago
    Change Detected
    Summary
    The website has been updated to version 2.14.0, adding a new type of intervention, while the previous version 2.13.3 has removed the type of intervention and helpful links related to the safety and efficacy of Lebrikizumab.
    Difference
    0.5%
    Check dated 2025-01-12T17:57:37.000Z thumbnail image

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.